Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
  • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
  • C07D471/04—Ortho-condensed systems
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
  • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
  • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P25/00—Drugs for disorders of the nervous system
  • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Health & Medical Sciences (AREA)
• General Health & Medical Sciences (AREA)
• Veterinary Medicine (AREA)
• Public Health (AREA)
• Medicinal Chemistry (AREA)
• Engineering & Computer Science (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Pharmacology & Pharmacy (AREA)
• Life Sciences & Earth Sciences (AREA)
• Animal Behavior & Ethology (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• General Chemical & Material Sciences (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Neurosurgery (AREA)
• Biomedical Technology (AREA)
• Neurology (AREA)
• Psychiatry (AREA)
• Epidemiology (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Nitrogen Condensed Heterocyclic Rings (AREA)
• Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
• Crystals, And After-Treatments Of Crystals (AREA)
• Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Applications Claiming Priority (2)

Publications (1)

Family

ID=46551819

Family Applications (1)

Country Status (26)

Families Citing this family (4)

Family Cites Families (16)

• 2012
  • 2012-06-20 TW TW101122358A patent/TWI570122B/zh not_active IP Right Cessation
  • 2012-06-21 US US14/125,390 patent/US9512118B2/en active Active
  • 2012-06-21 EP EP12738230.7A patent/EP2723738B1/en active Active
  • 2012-06-21 UY UY0001034150A patent/UY34150A/es not_active Application Discontinuation
  • 2012-06-21 WO PCT/JP2012/066461 patent/WO2012176934A1/en active Application Filing
  • 2012-06-21 CN CN201280029988.3A patent/CN103608348B/zh active Active
  • 2012-06-21 KR KR1020137034952A patent/KR20140040777A/ko not_active Application Discontinuation
  • 2012-06-21 AR ARP120102205A patent/AR087004A1/es unknown
  • 2012-06-21 MY MYPI2013004544A patent/MY163483A/en unknown
  • 2012-06-21 MX MX2013015354A patent/MX342990B/es active IP Right Grant
  • 2012-06-21 UA UAA201400581A patent/UA112082C2/uk unknown
  • 2012-06-21 GE GEAP201213352A patent/GEP20166475B/en unknown
  • 2012-06-21 EA EA201490092A patent/EA026137B1/ru not_active IP Right Cessation
  • 2012-06-21 CA CA2839825A patent/CA2839825C/en not_active Expired - Fee Related
  • 2012-06-21 AU AU2012274292A patent/AU2012274292B2/en not_active Ceased
  • 2012-06-21 BR BR112013032052A patent/BR112013032052A2/pt not_active IP Right Cessation
  • 2012-06-21 PE PE2013002859A patent/PE20141030A1/es not_active Application Discontinuation
  • 2012-06-21 JP JP2013557956A patent/JP6025757B2/ja active Active
• 2013
  • 2013-12-06 TN TNP2013000510A patent/TN2013000510A1/fr unknown
  • 2013-12-18 CL CL2013003632A patent/CL2013003632A1/es unknown
  • 2013-12-19 ZA ZA2013/09611A patent/ZA201309611B/en unknown
  • 2013-12-20 DO DO2013000311A patent/DOP2013000311A/es unknown
• 2014
  • 2014-01-20 MA MA36695A patent/MA35274B1/fr unknown
  • 2014-01-21 CO CO14010660A patent/CO6862150A2/es not_active Application Discontinuation
  • 2014-01-22 EC ECSP14013165 patent/ECSP14013165A/es unknown
  • 2014-01-22 CR CR20140033A patent/CR20140033A/es unknown

Also Published As

Similar Documents

Legal Events